Lea S Eiland
Overview
Explore the profile of Lea S Eiland including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
443
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sierra C, Capino A, M Petrea C, Eiland L, Fenn Iii N, Fusco N, et al.
J Pediatr Pharmacol Ther
. 2025 Feb;
30(1):4-7.
PMID: 39935571
No abstract available.
2.
Summerlin J, Eiland L
J Pediatr Pharmacol Ther
. 2025 Feb;
30(1):17-26.
PMID: 39935563
Children often experience viral illnesses causing respiratory symptoms. Frequently, nonprescription medications are used in an attempt to decrease the severity and frequency of cough and cold symptoms. Cough and cold...
3.
Steuber T, Trujillo D, Kleppinger E, Andrus M, Pinner N, Hornsby L, et al.
Am J Pharm Educ
. 2025 Feb;
89(3):101367.
PMID: 39924088
Objective: This study aimed to assess the impact of curricular content reduction in a 3-year integrated course sequence in a Doctor of Pharmacy curriculum on student-reported mental and physical health....
4.
Steuber T, Trujillo D, McCoy E, Pinner N, Hornsby L, Andrus M, et al.
Am J Pharm Educ
. 2024 May;
88(7):100721.
PMID: 38810952
Objective: To evaluate the effect of curricular content reduction in an integrated course sequence spanning 3 years of a Doctor of Pharmacy curriculum on student examination scores and course grades....
5.
Fly J, Eiland L, Stultz J
Ann Pharmacother
. 2024 Apr;
59(1):81-91.
PMID: 38654469
Objective: Review available data from clinical trials of nirsevimab for efficacy and safety in the setting of respiratory syncytial virus (RSV) prophylaxis in infants and children, while exploring nirsevimab's role...
6.
Eiland L, Gildon B
J Pediatr Pharmacol Ther
. 2024 Apr;
29(2):107-118.
PMID: 38596418
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders in childhood with approximately 6 million children (age 3 to 17 years) ever diagnosed based on data from 2016-2019....
7.
Eiland L, Steuber T
Curr Pharm Teach Learn
. 2023 Jul;
15(8):736-741.
PMID: 37479602
Introduction: We describe a two-year, stepwise curricular change plan with a goal to address student and faculty wellbeing by reducing curricular density and rescheduling courses. Methods: At year five of...
8.
Kinney S, Janzen K, Shields K, Tetenbaum-Novatt J, Mandal M, Owens R, et al.
Am J Pharm Educ
. 2023 Jun;
87(5):100049.
PMID: 37288679
Objectives: To explore the landscape of mentorship within professional associations in pharmacy academia, including reviewing available literature and describing currently available programs within the American Association of Colleges of Pharmacy,...
9.
Eiland L, Harris J, Holmes A
Ann Pharmacother
. 2023 Apr;
57(12):1415-1424.
PMID: 37076990
Objective: To provide nonobstetric practitioners with an overview of key concepts for the pregnant patient and review treatment of 3 common acute nonobstetric diseases encountered in the emergency department setting....
10.
Omecene N, Eiland L, Sierra C
J Am Pharm Assoc (2003)
. 2023 Apr;
63(4):1035-1038.
PMID: 37031954
Vaccines are a daycare and school requirement for children. The Public Readiness and Emergency Preparedness (PREP) Act 3rd amendment grants pharmacists and pharmacy interns the capability to vaccinate children at...